Overview

A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of zolpidem MR (modified release) compared to zolpidem IR (immediate release) in patients with primary insomnia.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Taiwan, Inc.
Treatments:
Zolpidem